Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1915 1
1946 2
1947 5
1948 2
1949 6
1950 6
1951 5
1952 8
1953 5
1954 6
1955 4
1956 9
1957 6
1958 8
1959 7
1960 11
1961 15
1962 3
1963 8
1964 6
1965 9
1966 11
1967 13
1968 16
1969 13
1970 14
1971 17
1972 16
1973 24
1974 11
1975 14
1976 16
1977 18
1978 24
1979 29
1980 25
1981 28
1982 29
1983 37
1984 35
1985 39
1986 31
1987 33
1988 34
1989 30
1990 34
1991 34
1992 52
1993 34
1994 40
1995 31
1996 33
1997 34
1998 53
1999 35
2000 51
2001 46
2002 39
2003 43
2004 51
2005 70
2006 74
2007 93
2008 87
2009 85
2010 87
2011 73
2012 83
2013 86
2014 86
2015 76
2016 72
2017 96
2018 84
2019 88
2020 89
2021 89
2022 91
2023 125
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

2,834 results

Results by year

Filters applied: . Clear all
Page 1
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Herold KC, et al. Among authors: marks jb. N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9. N Engl J Med. 2019. PMID: 31180194 Free PMC article. Clinical Trial.
Safety Assessment of Glycerin as Used in Cosmetics.
Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. Becker LC, et al. Among authors: marks jg jr. Int J Toxicol. 2019 Nov/Dec;38(3_suppl):6S-22S. doi: 10.1177/1091581819883820. Int J Toxicol. 2019. PMID: 31840548 Review.
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma.
Risom T, Glass DR, Averbukh I, Liu CC, Baranski A, Kagel A, McCaffrey EF, Greenwald NF, Rivero-Gutiérrez B, Strand SH, Varma S, Kong A, Keren L, Srivastava S, Zhu C, Khair Z, Veis DJ, Deschryver K, Vennam S, Maley C, Hwang ES, Marks JR, Bendall SC, Colditz GA, West RB, Angelo M. Risom T, et al. Among authors: marks jr. Cell. 2022 Jan 20;185(2):299-310.e18. doi: 10.1016/j.cell.2021.12.023. Cell. 2022. PMID: 35063072 Free PMC article.
Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD).
Slater BJ, Collings A, Dirks R, Gould JC, Qureshi AP, Juza R, Rodríguez-Luna MR, Wunker C, Kohn GP, Kothari S, Carslon E, Worrell S, Abou-Setta AM, Ansari MT, Athanasiadis DI, Daly S, Dimou F, Haskins IN, Hong J, Krishnan K, Lidor A, Litle V, Low D, Petrick A, Soriano IS, Thosani N, Tyberg A, Velanovich V, Vilallonga R, Marks JM. Slater BJ, et al. Among authors: marks jm. Surg Endosc. 2023 Feb;37(2):781-806. doi: 10.1007/s00464-022-09817-3. Epub 2022 Dec 18. Surg Endosc. 2023. PMID: 36529851
Archival single-cell genomics reveals persistent subclones during DCIS progression.
Wang K, Kumar T, Wang J, Minussi DC, Sei E, Li J, Tran TM, Thennavan A, Hu M, Casasent AK, Xiao Z, Bai S, Yang L, King LM, Shah V, Kristel P, van der Borden CL, Marks JR, Zhao Y, Zurita AJ, Aparicio A, Chapin B, Ye J, Zhang J, Gibbons DL; Grand Challenge PRECISION Consortium; Sawyer E, Thompson AM, Futreal A, Hwang ES, Wesseling J, Lips EH, Navin NE. Wang K, et al. Among authors: marks jr. Cell. 2023 Aug 31;186(18):3968-3982.e15. doi: 10.1016/j.cell.2023.07.024. Epub 2023 Aug 15. Cell. 2023. PMID: 37586362
Parabens.
Fransway AF, Fransway PJ, Belsito DV, Warshaw EM, Sasseville D, Fowler JF Jr, DeKoven JG, Pratt MD, Maibach HI, Taylor JS, Marks JG, Mathias CGT, DeLeo VA, Zirwas JM, Zug KA, Atwater AR, Silverberg J, Reeder MJ. Fransway AF, et al. Among authors: marks jg. Dermatitis. 2019 Jan-Feb;30(1):3-31. doi: 10.1097/DER.0000000000000429. Dermatitis. 2019. PMID: 30570578 Review.
Sulfites.
Johnson W Jr, Bergfeld WF, Belsito DV, Klaassen CD, Liebler DC, Marks JG, Peterson LA, Shank RC, Slaga TJ, Snyder PW, Fiume M, Heldreth B. Johnson W Jr, et al. Among authors: marks jg. Int J Toxicol. 2023 Dec;42(3_suppl):110S-114S. doi: 10.1177/10915818231204569. Epub 2023 Oct 16. Int J Toxicol. 2023. PMID: 37843013
Quaternium-26.
Johnson W Jr, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Fiume M, Heldreth B. Johnson W Jr, et al. Among authors: marks jg. Int J Toxicol. 2023 Dec;42(3_suppl):98S-99S. doi: 10.1177/10915818231204283. Epub 2023 Sep 28. Int J Toxicol. 2023. PMID: 37767968
Triacetin.
Fiume M, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Heldreth B. Fiume M, et al. Among authors: marks jg. Int J Toxicol. 2023 Dec;42(3_suppl):115S-116S. doi: 10.1177/10915818231204271. Epub 2023 Sep 29. Int J Toxicol. 2023. PMID: 37773996
2,834 results